Exclusive Worldwide Licensing Agreement with Cella Therapeutics Adds an Array of New Chemical Entities to Visus’ Drug Pipeline Agreement with DelSiTech for Sustained Drug Delivery Platform Allows ...
Eyenovia announces progress on its user-filled Optejet eye drop dispenser, aiming for U.S. regulatory approval in late 2025. Eyenovia, Inc. has made significant advancements in the development of its ...
ANDERNACH, Germany, April 29, 2026 /PRNewswire/ -- LTS LOHMANN Therapie-Systeme AG ("LTS"), a leading pharmaceutical technology company specializing in advanced drug delivery systems, today announced ...
Chaomu Technology (Beijing) Co. Ltd. has raised nearly ¥100 million (US$14 million) in a series A+ round to develop its ophthalmic medical devices. The proceeds from the financing will be used for the ...
Please provide your email address to receive an email when new articles are posted on . SAN FRANCISCO — The ophthalmic landscape is on the cusp of a “massive explosion” in technology, according to a ...
Please provide your email address to receive an email when new articles are posted on . Ophthalmic technology firm SVision Imaging is expanding its role in OCT imaging devices under the new name ...
2023 NOV 22 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Business Daily-- Current study results on Information Technology have been published. According to news reporting from ...
2022 FEB 08 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Business Daily-- Investigators publish new report on Information Technology. According to news originating from ...
SEATTLE--(BUSINESS WIRE)--Visus Therapeutics Inc., a clinical-stage pharmaceutical company focused on developing innovative ophthalmic therapies to improve vision for people around the world, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results